American Heart Association board names Fehlig, Tremwel to leadership posts

The American Heart Association (AHA) has named Chuck Fehlig its 2017-2018 Northwest Arkansas board chairman and Dr. Margaret Tremwel board president.

Fehlig, president and CEO of Fehlig & Associates, previously served on the Southwest Affiliate board of directors for the AHA, covering six states. He was Go Red For Women co-chair in 2015 and Heart Ball chair, with his wife Suzy Fehlig, in 2010. They have both supported the AHA for more than a decade.

Tremwel is a stroke neurologist and serves as medical director of the comprehensive stroke program at Washington Regional Medical Center in Fayetteville. She has served on the local board for three years and supports many of the AHA’s stroke initiatives. Tremwel also serves on the AHA’s Southwest Affiliate board and chairs the affiliate stroke committee.

“I am looking forward to serving as chairman with the AHA in Northwest Arkansas,” Fehlig said in a statement. “Coming from a family with a history of heart disease, it is important to me to support organizations that help drive real change in our community. My kids, grandkids and future generations are why this work is so important.”

The board’s priority is to build resource capacity and improve the health of NWA through education and community support. Other board members are: Lisa Christianson, PepsiCo; James Ely, Johnson & Johnson; Jason England, Arvest Bank; Debbie Jones, Bentonville School District, Dr. Richard Kyle, VA Hospital; Joe Mueller, Kellogg’s; Sharif Omar, Northwest Health System; Mario Palomino, PepsiCo; Charlotte Rankin, Mercy Health; Scott Roberts, Kellogg’s; Latriece Watkins, Wal-Mart Stores; Reg Yarbrough, Bayer HealthCare LLC.

“The board of directors strategically leads the American Heart Association towards achieving their 2020 Impact Goal,” said Kim Sloan, executive director of the Northwest Arkansas office of the American Heart Association. “We are working to improve the cardiovascular health of all Americans by 20% while reducing deaths from cardiovascular disease and stroke by 20%.”